|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
National Cancer Center Japan, . Cancer
Registry and Statistics. Cancer Information Service. https://ganjoho.jp/en/index.html1–March. 2022
|
|
3
|
Michl P and Gress TM: Improving drug
delivery to pancreatic cancer: Breaching the stromal fortress by
targeting hyaluronic acid. Gut. 61:1377–1379. 2012. View Article : Google Scholar
|
|
4
|
Cheng XB, Kohi S, Koga A, Hirata K and
Sato N: Hyaluronan stimulates pancreatic cancer cell motility.
Oncotarget. 7:4829–4840. 2016. View Article : Google Scholar
|
|
5
|
Itano N, Zhuo L and Kimata K: Impact of
the hyaluronan-rich tumor microenvironment on cancer initiation and
progression. Cancer Sci. 99:1720–1725. 2008. View Article : Google Scholar
|
|
6
|
Jacobetz MA, Chan DS, Neesse A, Bapiro TE,
Cook N, Frese KK, Feig C, Nakagawa T, Caldwell ME, Zecchini HI, et
al: Hyaluronan impairs vascular function and drug delivery in a
mouse model of pancreatic cancer. Gut. 62:112–120. 2013. View Article : Google Scholar
|
|
7
|
Provenzano PP, Cuevas C, Chang AE, Goel
VK, Von Hoff DD and Hingorani SR: Enzymatic targeting of the stroma
ablates physical barriers to treatment of pancreatic ductal
adenocarcinoma. Cancer Cell. 21:418–429. 2012. View Article : Google Scholar
|
|
8
|
Sato N, Kohi S, Hirata K and Goggins M:
Role of hyaluronan in pancreatic cancer biology and therapy: Once
again in the spotlight. Cancer Sci. 107:569–575. 2016. View Article : Google Scholar
|
|
9
|
Sironen RK, Tammi M, Tammi R, Auvinen PK,
Anttila M and Kosma VM: Hyaluronan in human malignancies. Exp Cell
Res. 317:383–391. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Toole BP, Wight TN and Tammi MI:
Hyaluronan-cell interactions in cancer and vascular disease. J Biol
Chem. 277:4593–4596. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Du Y, Cao M, Liu Y, He Y, Yang C, Wu M,
Zhang G and Gao F: Low-molecular-weight hyaluronan (LMW-HA)
accelerates lymph node metastasis of melanoma cells by inducing
disruption of lymphatic intercellular adhesion. Oncoimmunology.
5:e12322352016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu M, Tolg C and Turley E: Dissecting the
dual nature of hyaluronan in the tumor microenvironment. Front
Immunol. 10:9472019. View Article : Google Scholar
|
|
13
|
Sugahara KN, Hirata T, Hayasaka H, Stern
R, Murai T and Miyasaka M: Tumor cells enhance their own CD44
cleavage and motility by generating hyaluronan fragments. J Biol
Chem. 281:5861–5868. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu M, Cao M, He Y, Liu Y, Yang C, Du Y,
Wang W and Gao F: A novel role of low molecular weight hyaluronan
in breast cancer metastasis. FASEB J. 29:1290–1298. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cheng XB, Sato N, Kohi S and Yamaguchi K:
Prognostic impact of hyaluronan and its regulators in pancreatic
ductal adenocarcinoma. PLoS One. 8:e807652013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kohi S, Sato N, Cheng XB, Koga A and
Hirata K: Increased expression of HYAL1 in pancreatic ductal
adenocarcinoma. Pancreas. 45:1467–1473. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chowdhury AR, Ghosh I and Datta K:
Excessive reactive oxygen species induces apoptosis in fibroblasts:
Role of mitochondrially accumulated hyaluronic acid binding protein
1 (HABP1/p32/gC1qR). Exp Cell Res. 314:651–667. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
D'Souza M and Datta K: A novel
glycoprotein that binds to hyaluronic acid. Biochem Int. 13:79–88.
1986.
|
|
19
|
Li K, Gao B, Li J, Chen H, Li Y, Wei Y,
Gong D, Gao J, Zhang J, Tan W, et al: ZNF32 protects against
oxidative stress-induced apoptosis by modulating C1QBP
transcription. Oncotarget. 6:38107–38126. 2015. View Article : Google Scholar
|
|
20
|
Li Y, Wan OW, Xie W and Chung KK: p32
regulates mitochondrial morphology and dynamics through Parkin.
Neuroscience. 199:346–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu Y, Leslie PL, Jin A, Itahana K, Graves
LM and Zhang Y: p32 heterozygosity protects against age- and
diet-induced obesity by increasing energy expenditure. Sci Rep.
7:57542017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu Y, Leslie PL, Jin A, Itahana K, Graves
LM and Zhang Y: p32 regulates ER stress and lipid homeostasis by
down-regulating GCS1 expression. FASEB J. 32:3892–3902. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Muta T, Kang D, Kitajima S, Fujiwara T and
Hamasaki N: p32 protein, a splicing factor 2-associated protein, is
localized in mitochondrial matrix and is functionally important in
maintaining oxidative phosphorylation. J Biol Chem.
272:24363–24370. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Saha P and Datta K: Multi-functional,
multicompartmental hyaluronan-binding protein 1 (HABP1/p32/gC1qR):
Implication in cancer progression and metastasis. Oncotarget.
9:10784–10807. 2018. View Article : Google Scholar
|
|
25
|
Xie ZB, Yao L, Jin C, Zhang YF and Fu DL:
High cytoplasm HABP1 expression as a predictor of poor survival and
late tumor stage in pancreatic ductal adenocarcinoma patients. Eur
J Surg Oncol. 45:207–212. 2019. View Article : Google Scholar
|
|
26
|
Yagi M, Uchiumi T, Takazaki S, Okuno B,
Nomura M, Yoshida S, Kanki T and Kang D: p32/gC1qR is indispensable
for fetal development and mitochondrial translation: Importance of
its RNA-binding ability. Nucleic Acids Res. 40:9717–9737. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kaul R, Saha P, Saradhi M, Prasad RL,
Chatterjee S, Ghosh I, Tyagi RK and Datta K: Overexpression of
hyaluronan-binding protein 1 (HABP1/p32/gC1qR) in HepG2 cells leads
to increased hyaluronan synthesis and cell proliferation by
up-regulation of cyclin D1 in AKT-dependent pathway. J Biol Chem.
287:19750–19764. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Saha P, Ghosh I and Datta K: Increased
hyaluronan levels in HABP1/p32/gC1qR overexpressing HepG2 cells
inhibit autophagic vacuolation regulating tumor potency. PLoS One.
9:e1032082014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Brierley JD, Gospodarowicz MK and
Wittekind C: TNM classification of malignant tumours. 8th edition.
John Wiley & Sons; 2017
|
|
30
|
Wang J, Song Y, Liu T, Shi Q, Zhong Z, Wei
W, Huang S and Pang D: Elevated expression of HABP1 is a novel
prognostic indicator in triple-negative breast cancers. Tumour
Biol. 36:4793–4799. 2015. View Article : Google Scholar
|
|
31
|
Sato N, Mizumoto K, Beppu K, Maehara N,
Kusumoto M, Nabae T, Morisaki T, Katano M and Tanaka M:
Establishment of a new human pancreatic cancer cell line, NOR-P1,
with high angiogenic activity and metastatic potential. Cancer
Lett. 155:153–161. 2000. View Article : Google Scholar
|
|
32
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Vikramdeo KS, Saha P, Dutta S, Kumar N,
Roy Chowdhury A, Kumar S, Tyagi RK, Ghosh I and Datta K:
Hyaluronan-binding protein 1 (HABP1) overexpression triggers
induction of senescence in fibroblasts cells. Cell Biol Int.
44:1312–1330. 2020. View Article : Google Scholar
|
|
34
|
Prakash M, Kale S, Ghosh I, Kundu GC and
Datta K: Hyaluronan-binding protein 1 (HABP1/p32/gC1qR) induces
melanoma cell migration and tumor growth by NF-kappaB dependent
MMP-2 activation through integrin α(v)β(3) interaction. Cell
Signal. 23:1563–1577. 2011. View Article : Google Scholar
|
|
35
|
Niu M, Sun S, Zhang G, Zhao Y, Pang D and
Chen Y: Elevated expression of HABP1 is correlated with metastasis
and poor survival in breast cancer patients. Am J Cancer Res.
5:1190–1198. 2015.PubMed/NCBI
|
|
36
|
Yu H, Liu Q, Xin T, Xing L, Dong G, Jiang
Q, Lv Y, Song X, Teng C, Huang D, et al: Elevated expression of
hyaluronic acid binding protein 1 (HABP1)/P32/C1QBP is a novel
indicator for lymph node and peritoneal metastasis of epithelial
ovarian cancer patients. Tumour Biol. 34:3981–3987. 2013.
View Article : Google Scholar
|
|
37
|
Gao H, Yao Q, Lan X, Li S, Wu J, Zeng G
and Xue Y: Elevated HABP1 protein expression correlates with
progression and poor survival in patients with gastric cancer. Onco
Targets Ther. 9:6711–6718. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang M, Li N, Liang Y, Liu J, Zhou Y and
Liu C: Hyaluronic acid binding protein 1 overexpression is an
indicator for disease-free survival in cervical cancer. Int J Clin
Oncol. 22:347–352. 2017. View Article : Google Scholar
|
|
39
|
Jiang Y, Wu H, Liu J, Chen Y, Xie J, Zhao
Y and Pang D: Increased breast cancer risk with HABP1/p32/gC1qR
genetic polymorphism rs2285747 and its upregulation in northern
Chinese women. Oncotarget. 8:13932–13941. 2017. View Article : Google Scholar
|
|
40
|
Zhao J, Liu T, Yu G and Wang J:
Overexpression of HABP1 correlated with clinicopathological
characteristics and unfavorable prognosis in endometrial cancer.
Tumour Biol. 36:1299–1306. 2015. View Article : Google Scholar
|
|
41
|
Li X, Eguchi T, Aly RG, Chintala NK, Tan
KS, Zauderer MG, Dembitzer FR, Beasley MB, Ghebrehiwet B,
Adusumilli PS and Peerschke EIB: Globular C1q receptor
(gC1qR/p32/HABP1) is overexpressed in malignant pleural
mesothelioma and is associated with increased survival in surgical
patients treated with chemotherapy. Front Oncol. 9:10422019.
View Article : Google Scholar
|
